AKN Safety First Trust Principal-Protected Trust Certificates Linked TO A U.S.-Europe-Japan Basket Structured Product

Akorn, Inc. (AMEX: AKN) today announced the positive results of a Phase III pivotal trial for Akten�. The clinical trial was a randomized, placebo controlled, multi-centered, 4-arm trial in 209 subjects. The primary efficacy end point for achieving ocular anesthesia (p